In particular, SPG11 encodes spatacsin, another inhibitor of bone morphogenic protein signaling, supporting the involvement of this pathway in motor neuron degeneration and pathogenesis of both ALS and HSP. Here, SPG11 is linked to hereditary spastic paraplegia.